跳至主要内容
临床试验/ACTRN12616001690448
ACTRN12616001690448招募中未知

Multi-parametric Magnetic Resonance Imaging (MRI) for Therapeutic Response Prediction in Rectal Cancer

Dr Trang Pham0 个研究点目标入组 35 人开始时间: 2016年12月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age greater than 18
  • 2.Stage II or III rectal adenocarcinoma, defined as T3 - T4 and/or node positive disease (N1-2), without distant metastatic disease (M0)
  • 3.No evidence of metastatic disease on CT chest/abdomen/pelvis
  • 4.Undergoing treatment algorithm consisting of neoadjuvant chemoradiotherapy (radiotherapy 50.4Gy in 28 fractions concurrent with infusional 5-fluorouracil or oral capecitabine) followed by surgery at 6 to 12 weeks post chemoradiotherapy.

排除标准

  • 1.Other malignancy
  • 2.Active inflammatory bowel disease
  • 3.On concurrent high-dose corticosteroids (the equivalent of 50mg prednisone daily)
  • 4.Inability to have MRI due to:
  • a. Implanted magnetic metal eg. Intraocular metal
  • b. Pacemaker / Implantable defibrillator
  • c. Extreme claustrophobia.

研究者

发起方
Dr Trang Pham

相似试验